Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TALQUETAMAB-TGVS: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

44.5%
Female
55.5%
Male

Age Information

The average age of patients reporting adverse events with TALQUETAMAB-TGVS is 65.0 years.

Geographic Distribution

The majority of adverse event reports for TALQUETAMAB-TGVS originate from US.

Report Summary & Outcomes

828
Total Reports
828
As Primary/Secondary Suspect
63
Deaths Reported
141
Hospitalizations
23
Life-Threatening
4
Disabilities

Reporting Timeline

First adverse event report: 20211001. Most recent report: 20250916. View full timeline →

More About TALQUETAMAB-TGVS

TALQUETAMAB-TGVS Full Profile Reports by Year Drug Interactions